Abpro Corporation Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Abpro Corporation's estimated annual revenue is currently $7.1M per year.(i)
  • Abpro Corporation's estimated revenue per employee is $182,821

Employee Data

  • Abpro Corporation has 39 Employees.(i)
  • Abpro Corporation grew their employee count by 3% last year.

Abpro Corporation's People

NameTitleEmail/Phone
1
CEO and Co-FounderReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Associate Director, Antibody DiscoveryReveal Email/Phone
4
Director Corporate DevelopmentReveal Email/Phone
5
Senior Research AssociateReveal Email/Phone
6
Strategic and Operations ManagementReveal Email/Phone
7
Senior Director/Head Nonclinical Research and DevelopmentReveal Email/Phone
8
Senior Research AssociateReveal Email/Phone
9
Chairman and Co-FounderReveal Email/Phone
10
Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M1-50%N/AN/A
#3
$5.1M3322%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M2-60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
N/A1110%N/AN/A
#10
$5.4M290%N/AN/A
Add Company

What Is Abpro Corporation?

Abpro Corporation is a clinical-stage biotechnology company located in Woburn, Massachusetts. The Company's mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro's DiversImmuneâ„¢ platform has been used successfully against 300 traditionally difficult targets. The Company has a pipeline of therapies to treat cancer, eye, autoimmune, infectious diseases and other areas. For more information, please visit https://abpro.com/

keywords:N/A

N/A

Total Funding

39

Number of Employees

$7.1M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.4M39-20%N/A
#2
$6.5M3956%N/A
#3
$11M390%N/A
#4
$4.4M408%N/A
#5
$13M40-9%N/A